NO2019009I1 - abemaciclib or pharmaceutically acceptable salts thereof - Google Patents

abemaciclib or pharmaceutically acceptable salts thereof

Info

Publication number
NO2019009I1
NO2019009I1 NO2019009C NO2019009C NO2019009I1 NO 2019009 I1 NO2019009 I1 NO 2019009I1 NO 2019009 C NO2019009 C NO 2019009C NO 2019009 C NO2019009 C NO 2019009C NO 2019009 I1 NO2019009 I1 NO 2019009I1
Authority
NO
Norway
Prior art keywords
abemaciclib
pharmaceutically acceptable
acceptable salts
salts
pharmaceutically
Prior art date
Application number
NO2019009C
Other languages
Norwegian (no)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09775477.4A external-priority patent/EP2379528B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO2019009I1 publication Critical patent/NO2019009I1/en

Links

NO2019009C 2008-12-22 2019-02-20 abemaciclib or pharmaceutically acceptable salts thereof NO2019009I1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08380343 2008-12-22
US15495409P 2009-02-24 2009-02-24
EP09775477.4A EP2379528B1 (en) 2008-12-22 2009-12-15 Protein kinase inhibitors
PCT/US2009/068030 WO2010075074A1 (en) 2008-12-22 2009-12-15 Protein kinase inhibitors

Publications (1)

Publication Number Publication Date
NO2019009I1 true NO2019009I1 (en) 2019-02-20

Family

ID=65632957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2019009C NO2019009I1 (en) 2008-12-22 2019-02-20 abemaciclib or pharmaceutically acceptable salts thereof

Country Status (5)

Country Link
CL (1) CL2011001527A1 (en)
LT (1) LTC2379528I2 (en)
LU (1) LUC00106I2 (en)
NL (1) NL300969I2 (en)
NO (1) NO2019009I1 (en)

Also Published As

Publication number Publication date
LUC00106I1 (en) 2019-02-27
CL2011001527A1 (en) 2011-11-25
LTPA2019004I1 (en) 2019-03-12
LUC00106I2 (en) 2019-12-27
NL300969I1 (en) 2019-02-27
NL300969I2 (en) 2019-03-20
LTC2379528I2 (en) 2019-11-25

Similar Documents

Publication Publication Date Title
NO2019010I1 (en) Eravacycline or pharmaceutically acceptable salts thereof
NO2020037I1 (en) alpelisib or a pharmaceutically acceptable salt thereof
NO2019024I1 (en) Brigatinib or a pharmaceutically acceptable salt thereof
NO2020008I1 (en) nusinersen or its salts
NO2016014I2 (en) ceritinib or pharmaceutically acceptable salts thereof
NO2020042I1 (en) Entrektinib or isomers, tautomers, or pharmaceutically acceptable salts thereof
NO2017059I1 (en) ribosyclib or a pharmaceutically acceptable salt thereof
NO2020034I1 (en) Ozanimod or a pharmaceutically acceptable salt thereof, particularly ozanimod hydrochloride
NO2019042I1 (en) Talazoparib, optionally in the form of a pharmaceutically acceptable salt
NO2017033I1 (en) baricitinib and pharmaceutically acceptable salts thereof
NO2015014I1 (en) Paritaprevir, or a pharmaceutically acceptable salt or ester thereof
NO2015012I1 (en) Ombitasvir, or a pharmaceutically acceptable salt thereof
DK2308877T3 (en) Imidazopyridine-2-one derivatives
BRPI0919447A2 (en) 1-amino-2-cyclobutylethylboronic acid derivatives
NL301214I2 (en) Lasmiditan and pharmaceutically acceptable salts thereof
DK2275414T3 (en) CYCLOPENTYLACRYLAMIDE DERIVATIVES
ATE534634T1 (en) 2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
DK2380892T3 (en) IMIDAZOTHIAZOLD DERIVATIVES WITH PROLINING STRUCTURE
BRPI0921578A2 (en) unitemporal vaccines
BRPI0920293A2 (en) nacelle
NO2019009I1 (en) abemaciclib or pharmaceutically acceptable salts thereof
TH105092B (en) Benzoquinasoline derivatives
TH106414B (en) chair
TH106751B (en) chair
TH100454B (en) chair